Well-differentiated thyroid cancer
GH Jossart, OH Clark - Current problems in surgery, 1994 - Elsevier
Much progress has been made in our understanding of the epidemiologic factors, biologic
behavior, diagnosis, treatment, and molecular biology of well-differentiated thyroid …
behavior, diagnosis, treatment, and molecular biology of well-differentiated thyroid …
Distant metastases from thyroid and parathyroid cancer
AR Shaha, A Ferlito, A Rinaldo - ORL, 2001 - karger.com
Thyroid cancer represents a unique biological tumor where even with the high incidence of
distant metastases, the overall prognosis is not as poor as many other human cancers. The …
distant metastases, the overall prognosis is not as poor as many other human cancers. The …
Clinical course of thyroid carcinoma after neck dissection
MD Shah, FT Hall, SJ Eski, IJ Witterick… - The …, 2003 - Wiley Online Library
Abstract Objectives/Hypothesis The objective was to compare the rate and site of
recurrences in patients with well‐differentiated thyroid carcinoma who underwent a central …
recurrences in patients with well‐differentiated thyroid carcinoma who underwent a central …
Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma
FT Hall, JL Freeman, SL Asa… - … –head & neck surgery, 2003 - jamanetwork.com
Objective To examine the relationship between lymphatic vessel density and clinical and
pathological variables in patients with well-differentiated papillary thyroid carcinoma …
pathological variables in patients with well-differentiated papillary thyroid carcinoma …
The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering …
Background: The American Thyroid Association guidelines recommend the routine use of
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
radioactive iodine for remnant ablation (RRA) in all T3 or greater primary tumors, and …
Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer
K Semsar-Kazerooni, GB Morand… - … -Head & Neck …, 2022 - journals.sagepub.com
Background In clinical practice, thyroid tumor size plays a critical role in the staging of
thyroid malignancies and in the selection of nodules that should undergo ultrasound-guided …
thyroid malignancies and in the selection of nodules that should undergo ultrasound-guided …
Recurrent differentiated thyroid cancer
AR Shaha - Endocrine Practice, 2012 - Elsevier
Objective To discuss the risk of recurrence in patients with differentiated thyroid cancer and
emphasize the importance of risk-group stratification. Methods Common risk factors …
emphasize the importance of risk-group stratification. Methods Common risk factors …
Sonographic detection of extracapsular extension in papillary thyroid cancer
A Kamaya, AM Tahvildari, BN Patel… - … of Ultrasound in …, 2015 - Wiley Online Library
Objectives To identify and evaluate sonographic features suggestive of extracapsular
extension in papillary thyroid cancer. Methods Three board‐certified radiologists blinded to …
extension in papillary thyroid cancer. Methods Three board‐certified radiologists blinded to …
Results of the treatment of locally invasive thyroid carcinoma
LP Kowalski, JG Filho - Head & Neck: Journal for the Sciences …, 2002 - Wiley Online Library
Background Well‐differentiated thyroid carcinoma usually has an excellent prognosis.
However, when extrathyroidal invasion occurs, it is associated with significant morbidity and …
However, when extrathyroidal invasion occurs, it is associated with significant morbidity and …
Invasive thyroid cancer: management of the trachea and esophagus
DL Price, RJ Wong, GW Randolph - Otolaryngologic Clinics of North …, 2008 - Elsevier
Well-differentiated thyroid cancer most commonly presents as an intrathyroidal tumor;
however, extrathyroidal extension occurs in approximately 6% to 13% of patients and carries …
however, extrathyroidal extension occurs in approximately 6% to 13% of patients and carries …